Did you know that there are currently 38 clinical studies and researches being carried out at Pantai Hospital Kuala Lumpur to improve quality of care and clinical outcomes? These are driven by none other than Malaysia Operation’s first Research & Innovation Department set up in November last year.
Senior Research Scientist Dr Wong Shin Yee, a PhD holder in Molecular Medicine, heads the new department, supported by a team of experienced study coordinators and research assistants. For months now, they have been working with different stakeholders on the 38 approved studies that span multiple medical fields.
Cancer therapy is the current research focus, with 14 oncology clinical trials underway relating to breast cancer and non-small cell lung carcinoma. In addition, there are five oncology studies initiated by the consultants at Pantai Hospital Kuala Lumpur to determine the clinical outcomes of cancer patients at Pantai Hospital Kuala Lumpur.
The team is making good headway and looks forward to share their research outcomes soon. Stay tuned.
Related Stories
Gleneagles Hospital Hong Kong Launches TeleCare SmartHub with SmarTone
Combining clinical expertise with digital capabilities, the new TeleCare SmartHub enables residents to access professional medical consultations and health monitoring services closer to home.
IHH Healthcare Singapore and AIA Singapore Partner to Advance Value-based Care
IHH Singapore Advances the Conversation on Healthspan and Longevity
The IHH Sky Race Reaches New Heights at Merdeka 118
Fortis Memorial Research Institute Champions ECMO Excellence at ECMOASIA 2026
On 24-25 July 2026, Fortis Memorial Research Institute (FMRI), Gurugram hosted ECMOASIA 2026, a landmark conference that brought together leading national and international experts to advance awareness, education and clinical excellence in Extracorporeal Membrane Oxygenation (ECMO) care across the Asia-Pacific region.
Pantai Hospital Kuala Lumpur Brings Preventive Care to the Workplace
On 12 August, Pantai Hospital Kuala Lumpur (PHKL) partnered with Unitrade Industries Berhad and AIA Malaysia to deliver an On-Site Influenza Vaccination and Health Screening Programme at Unitrade's premises, bringing accessible preventive care directly to the workplace.
